Loading…
Loading…
With the continued growth and expansion of the cannabis industry, companies are witnessing another shift. Between the USA and Canada, more companies are focused on better branding and marketing attached to better quality products. Right now, in legal cannabis, it is the battle of genetics and who has what and who is inside their legal facilities. As cannabis becomes more mainstream, consumers, like anything else, want reliable products from top brands.
Trulieve Cannabis Corp. (NYSE:TRLV) rang in a new era for the U.S. cannabis industry on Wednesday, becoming the first American marijuana company to list on a major U.S. stock exchange.
The cannabis sector continues evolving as operators focus on profitability, cash flow, and market expansion. Federal cannabis reform discussions remain a major catalyst. Meanwhile, leading multistate operators continue strengthening their positions across key U.S. markets. Investors searching for cannabis exposure may want to focus on companies with strong retail footprints and improving financial performance.
TALLAHASSEE, Fla., June 9, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that its Board of Directors authorized a share repurchase program pursuant to which the Company may repurchase up to the lesser of (i) $50 million in aggregate value, and (ii) 8,495,038 subordinate voting shares of the Company (being five percent (5%) of the Company's issued and outstanding subordinate voting shares as at June 8, 2026) over a 12-month period.
Green Thumb Industries and Tilray are in a strong position to benefit from the reclassification of cannabis as a Schedule III drug. Tilray is well positioned to expand its U.S. operations.
Subordinate Voting Shares expected to begin trading under ticker "TRLV" on Wednesday, June 10 TALLAHASSEE, Fla., June 5, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that its subordinate voting shares (the "Subordinate Voting Shares") have been approved for listing on the New York Stock Exchange ("NYSE").
As June 2026 begins, cannabis investors continue searching for companies with strong operations and improving profitability. Although the industry still faces regulatory challenges, many leading operators have strengthened their balance sheets. Additionally, several companies continue generating significant revenue despite difficult market conditions.
The post-280E era will usher in new winners among cannabis stocks.